H.U. Group's Lab-Testing Unit Turns Profitable as Alzheimer's Test Clears Europe
H.U. Group Holdings swung to a ¥1.57bn quarterly profit as price adjustments fixed its loss-making testing-services unit, while a blood-based Alzheimer's diagnostic won certification in Europe.